SRPT - Sarepta Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts18181717
Avg. Estimate-1.33-1.24-7.3-4.04
Low Estimate-1.63-1.96-9.12-6.75
High Estimate-1.010.09-5.15-1.83
Year Ago EPS-1.15-2.05-5.46-7.3
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts19192120
Avg. Estimate100.57M113.48M394.44M598.76M
Low Estimate95M98M371M456.91M
High Estimate110.1M134.7M426.5M951.92M
Year Ago Sales78.49M84.42M301.03M394.44M
Sales Growth (year/est)28.10%34.40%31.00%51.80%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.81-1.02-1.7-1.37
EPS Actual-1.15-2.05-1.07-3.74
Difference-0.34-1.030.63-2.37
Surprise %-42.00%-101.00%37.10%-173.00%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.33-1.24-7.3-4.04
7 Days Ago-1.33-1.24-7.3-4.03
30 Days Ago-1.14-1.02-4.79-2.96
60 Days Ago-1.14-1.01-4.5-2.94
90 Days Ago-1.14-1.02-4.5-2.94
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/A1N/A
Up Last 30 Days2112
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days91091
Growth EstimatesSRPTIndustrySectorS&P 500
Current Qtr.-15.70%N/AN/A-0.00
Next Qtr.39.50%N/AN/A0.08
Current Year-33.70%N/AN/A0.03
Next Year44.70%N/AN/A0.10
Next 5 Years (per annum)-0.20%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A